Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
MOLECULAR AND CELLULAR PATHOGENESIS

Cytocidal and Apoptotic Effects of the ClyA Protein from Escherichia coli on Primary and Cultured Monocytes and Macrophages

Xin-He Lai, Ignacio Arencibia, Anders Johansson, Sun Nyunt Wai, Jan Oscarsson, Sotos Kalfas, Karl-Gösta Sundqvist, Yoshimitsu Mizunoe, Anders Sjöstedt, Bernt Eric Uhlin
Xin-He Lai
Departments of Microbiology,
Clinical Bacteriology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ignacio Arencibia
Clinical Immunology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anders Johansson
Oral Biology, Umeå University, S-901 87 Umeå, Sweden, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sun Nyunt Wai
Departments of Microbiology,
Department of Bacteriology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Oscarsson
Departments of Microbiology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sotos Kalfas
Oral Biology, Umeå University, S-901 87 Umeå, Sweden, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl-Gösta Sundqvist
Clinical Immunology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshimitsu Mizunoe
Department of Bacteriology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anders Sjöstedt
Clinical Bacteriology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernt Eric Uhlin
Departments of Microbiology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.68.7.4363-4367.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Cytolysin A (ClyA) is a newly discovered cytolytic protein ofEscherichia coli K-12 that mediates a hemolytic phenotype. We show here that highly purified ClyA and ClyA-expressing E. coli were cytotoxic and apoptogenic to fresh as well as cultured human and murine monocytes/macrophages.

Recently it was discovered that a chromosomal gene denoted clyA (also referred to assheA and hlyE) in Escherichia coliK-12 encodes a novel hemolytic protein (5, 20, 21, 24, 25, 28; Y. Mizunoe and B. E. Uhlin, Abstr. 34th Intersci. Conf. Antimicrob. Agents Chemother., abstr. B37, 1994). However, the gene product, the 34-kDa cytolysin A (ClyA) protein, does not seem to be expressed under normal laboratory conditions. This normally latentclyA gene can be activated either by mutation in thehns locus or by overexpression of several putative regulatory genes (5, 8, 9, 19-21, 24, 25, 28; Mizunoe and Uhlin, 34th ICAAC). Both purified ClyA and ClyA-expressingE. coli are able to lyse erythrocytes from several mammalian species in both solid and liquid media, and we recently found that the protein is cytotoxic to macrophages grown in tissue culture (5, 8, 9, 19-21, 24, 25, 28; Mizunoe and Uhlin, 34th ICAAC). Those findings prompted us to further investigate the interaction of ClyA-producing bacteria and purified ClyA with mammalian cells.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Cytotoxicity as manifested by LDH release from murine macrophages J774. About 2 × 104 cells were seeded each well in 96-well plates and treated with highly purified ClyA or infected at different MOIs with ClyA-expressing or vector control E. coli as described elsewhere (17, 18, 24). Killing was assayed at several time intervals and expressed as percent cytotoxicity. Data are means ± standard deviations (n = 4) from one representative experiment of three. The E. coli strains used here do not have endogenous LDH activity when grown aerobically. (A) Dose-dependent toxicity of purified ClyA. Cells were pretreated with PMA as described elsewhere (24). (B) Cytotoxicity of ClyA-expressing E. coliMC1061/pYMZ80 compared with its plasmid vector control MC1061/pUC18 at an MOI of 100. (C) Infection dose-dependent toxicity of ClyA-expressingE. coli (MOI of 100 versus 10).

Cytotoxic effects of purified ClyA protein and ClyA-expressingE. coli on fresh or cultured human and murine monocytes/macrophages.Cell morphology changes and detachment from culture plates are conventional and useful indicators to monitor bacterial cytotoxicity. We recently described that highly purified ClyA can detach J774 macrophages from culture plates and change their cell morphology (24). In the present study, we extended our cytotoxicity measurements to other types of host cells by using a neutral red uptake assay (2) and a quantitative lactate dehydrogenase (LDH) release assay based on the fact that LDH is a strictly cytoplasmic enzyme and its presence in the culture medium reflects the disruption of the host cell plasma membrane (16).

The macrophage cell lines J774 (murine) and U937 (human) were maintained and treated as described previously (17, 18, 24, 26, 27). Human polymorphonuclear leukocytes and monocytes were isolated following a standardized procedure as described previously (11, 13). Highly purified ClyA preparations were obtained from E. coli K-12 cells carrying clone pYMZ80 (24; S. N. Wai and B. E. Uhlin, unpublished data). Proteins were diluted in complete medium and sterilized by filtration through a 0.22-μm-pore-size membrane (Schleicher & Schuell FD 030/3). J774 cells, polymorphonuclear leukocytes, or monocytes were treated with purified and filtrated ClyA in 200 μl (total volume) of cell medium. In some experiments, cells were pretreated with phorbol 12-myristate 13-acetate (PMA; Sigma) as described before (24). For testing the effect of cytochalasin D (4) on cytotoxicity, cells were pretreated with 1 μg of cytochalasin D (Sigma) ml−1 for 30 min before bacterial infection, and cytochalasin D was maintained throughout the experiment. Treatment of the bacteria and eukaryotic cells with cytochalasin D at the above concentration did not significantly reduce cell or bacterial viability (data not shown).E. coli strains MC1061/pUC18 and MC1061/pYMZ80 were used as described elsewhere (24). J774 cells were infected as described elsewhere (17, 18, 24) with bacteria at a multiplicity of infection (MOI) of 100, unless otherwise indicated.

As shown in Fig. 1, LDH release was both ClyA concentration and bacterial infection dose (i.e., MOI) dependent. ClyA at 20 μg ml−1 caused more than 20% LDH release after 2 h of treatment, while no detectable LDH release came from cells treated with one-sixth as much ClyA (Fig. 1A). LDH release remained at baseline level for the vector control MC1061/pUC18, whereas the ClyA-expressing strain MC1061/pYMZ80 was cytotoxic to J774 macrophages at each time interval tested (Fig. 1B and C). MC1061/pYMZ80 showed approximately one-third as much cytotoxicity at an MOI of 10 compared with that at an MOI of 100, at both 2 and 4 h postinfection (p.i.). The cytotoxicity was even greater at 6 h p.i. and approached a level similar to that at the higher MOI (Fig.1C). The kinetics of cytotoxicity within 6 h of treatment over three time intervals are shown in Fig. 1.

The effect of ClyA on viability of human primary monocytes was monitored using a neutral red uptake assay as described before (2, 11, 13). The viability of freshly isolated human peripheral monocytes showed a dose-related decline after treatment with ClyA for 20 h (Fig. 2), and the effect was similar to that seen with cultured J774 macrophages. Exposure of human peripheral blood lymphocytes or monocytes to 10 μg of ClyA ml−1 for 1 h caused about 20% LDH release, which is comparable to the cytotoxicity level of ClyA on cultured macrophages (Fig. 1A).

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Viability results of neutral red uptake by human peripheral monocytes after 20 h of ClyA treatment. Cells (about 2 × 105 cells per well in 96-well plates) were prepared, treated, and assayed as described elsewhere (2, 11, 13). Viability value (neutral red uptake) of untreated cells was taken as 100%. Note the ClyA dose-dependent tendency.

Apoptosis judged by DNA fragmentation of macrophages infected with ClyA-expressing E. coli or treated with purified ClyA.The biochemical hallmark of apoptosis is the cleavage of chromatin into nucleosomal fragments, resulting in multimers of 180 to 200 bp (15, 30). However, it has been reported that necrotic cells may have irregular DNA fragmentation and generate higher-molecular-weight DNA fragments (23). We used three complementary assays to determine whether the predominant macrophage cell death induced by these treatments was due to apoptosis.

Photometric determination of the histone-associated DNA fragments released by the treated cells was performed with the sensitive cell death detection enzyme-linked immunosorbent assay (ELISA; Boehringer Mannheim GmbH) according to the manufacturer's instructions and as described elsewhere (18). Substrate reaction time was 15 min. Both ClyA-expressing E. coli MC1061/pYMZ80 (Fig.3A and C) and purified ClyA (Fig. 3B) induced strong signals representing small DNA fragments released to the cell supernatant.

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Fragmentation of DNA in human and murine macrophages (about 2 × 104 cells per well in 96-well plates) as assayed by ELISA. Data are means ± standard deviations of duplicate samples from one representative experiment of two. Shown are results for infected murine macrophages J774 at 12 h p.i. at an MOI of 100 (A), J774 cells treated with purified ClyA for 12 h (B), and infected human macrophages U937 at 6 h p.i. at an MOI of 100 (C). Bars: 1, vector strain MC1061/pUC18; 2, ClyA-expressing strain MC1061/pYMZ80; 3, Tris-HCl buffer (20 mM, pH 7.5); 4, purified ClyA protein (20 μg ml−1); 5, MC1061/pUC18; 6, MC1061/pYMZ80.

Macrophage apoptosis was further quantified by TUNEL (terminal deoxynucleotidyltransferase [TdT]-mediated dUTP nick end labeling [7])-FACS (fluorescence-activated cell sorting) analysis of the treated cells exactly as described before (18). A ClyA-expressing strain caused about the same percentage of apoptosis in both murine and human macrophages (Fig.4B and G), while the levels with the vector control remained at baseline (Fig. 4A and F). The dose- and time-dependent effect of purified ClyA shown in the cytotoxicity measurements was also evident in this TUNEL-FACS analysis. J774 cells had an apoptosis percentage of about 15% when exposed to 10 μg of ClyA for 36 h (Fig. 4D), and there were 96% apoptotic cells when 10 times more ClyA was added (Fig. 4E); in contrast, values for cells in the control wells (containing Tris-HCl buffer [20 mM, pH 7.5] instead of ClyA protein) remained at the background level (Fig. 4C). The ClyA-treated cells did not show values above the baseline level during the first 12 h (data not shown). It should be noted that more cells were needed in the TUNEL-FACS experiment (about 5 × 106 cells) than in the cytotoxicity and ELISA experiments (about 2 × 104 cells) described above.

Fig. 4.
  • Open in new tab
  • Download powerpoint
Fig. 4.

Quantitative TUNEL-FACS measurements of apoptosis of infected (MOI of 100) J774 (A and B) and U937 (F and G) macrophages at 12 h (data from one of two repeated tests which gave similar results) or ClyA-treated J774 cells at 36 h (C to E), using FACScan LYSIS II or CellQuest. The quantified percentages of apoptosis are shown. The y axis represents the number of cells (10,000); the x axis represents fluorescence intensity. Shaded areas are macrophages with TdT and overlaid by cells without TdT. The initial cell number in each well of a six-well plate was about 5 × 106. (A) Vector control strain MC1061/pUC18; (B) ClyA-expressing strain MC1061/pYMZ80; (C) Tris-HCl buffer (20 mM, pH 7.5); (D) ClyA (10 μg); (E) ClyA (100 μg); (F) vector control strain MC1061/pUC18; (G) ClyA-expressing strain MC1061/pYMZ80.

DNA of the infected macrophages was extracted as follows. Cells were harvested and treated with lysis buffer (1% NP-40 in 20 mM EDTA–50 mM Tris-HCl [pH 7.5]) (10) at 37°C. The lysates were extracted once with an equal volume of phenol and once with an equal volume of chloroform-isoamyl alcohol (24:1, vol/vol) before precipitation with ethanol. The precipitates were dried and solubilized in 10 mM Tris (pH 8.0)–1 mM EDTA. Electrophoresis was performed with a 1.5% agarose gel containing 0.5 μg of ethidium bromide ml−1 in Tris-acetate-EDTA buffer (pH 8.2). DNA was visualized by UV light and photographed. As evidenced by electrophoresis of genomic DNA, a nucleosome ladder pattern of DNA degradation was observed in J774 cells infected with MC1061/pYMZ80 but not in J774 cells infected with the vector control MC1061/pUC18 (Fig. 5). It was also evident that cytochalasin D did not inhibit the apoptogenic property of MC1061/pYMZ80 on J774 cells (Fig. 5, lane 4) under the conditions used here.

Fig. 5.
  • Open in new tab
  • Download powerpoint
Fig. 5.

Fragmentation of genomic DNA from about 5 × 106 to 1 × 107 J774 macrophages infected with MC1061/pYMZ80 at an MOI of 100 with or without cytochalasin D (Cyt-D) at 12 h p.i. DNA purification and gel electrophoresis were carried out as described in the text. MC1061/pYMZ80-infected cells generated ladders of multimers of 180 bp characteristic of apoptosis. Lanes: 1, 100-bp DNA ladder; 2, vector control strain MC1061/pUC18; 3, ClyA-expressing strain MC1061/pYMZ80; 4, ClyA-expressing strain MC1061/pYMZ80 with 1 μg of Cyt-D ml−1.

It is roughly estimated in recent studies that pores generated by ClyA (about 2.5 to 3 nm) appear to be somewhat larger than those generated by HlyA (20, 21, 24, 29). The damaged host cell membrane might allow the influx and/or efflux of certain ions which could trigger apoptosis directly or indirectly (1, 12, 22, 23). Thus, the pore-forming activity of ClyA might be responsible for induction of apoptosis as described for other pore-forming toxins (6, 14). Ca2+ is generally regarded as a common signal for initiation of apoptosis. Increase in calcium concentration has been shown to activate degradative processes in programmed cell death directly by stimulating endonucleases or indirectly by promoting activation of calcium-dependent proteases and phosphatases (1, 3, 12, 22, 23). One may speculate that the pore-forming property of ClyA could cause the modification of the intracellular level of Ca2+, which may in turn trigger the apoptosis cascade. The Ca2+- and Mg2+-dependent endonuclease activated during the apoptotic process cleaves the genomic DNA at the internucleosomal regions, thereby generating mono- and oligonucleosomes.

Conclusions.Taken together, our data demonstrate that purified ClyA and a ClyA-expressing E. coli strain were cytotoxic to both human and murine macrophages in a dose- and time-dependent way and induced a massive amount of apoptosis as determined by several assays showing host cell DNA fragmentation. Further studies will hopefully elucidate the precise mechanisms of ClyA-induced apoptosis of host cells. Our findings that this protein, in addition to being merely a hemolysin, is more widely cytocidal and has the capacity to induce macrophage apoptosis should prompt studies of how ClyA might contribute to pathogenicity of certainE. coli strains.

ACKNOWLEDGMENTS

We are grateful to Guangqian Zhou for supplying a sample of PMA.

This work was supported by grants from the Swedish Natural Science Research Council, the Swedish Medical Research Council, the Swedish Institute, the Wenner-Gren Foundations, and the Göran Gustafsson Foundation for Research in Natural Sciences and Medicine.

Notes

Editor: J. T. Barbieri

FOOTNOTES

    • Received 4 November 1999.
    • Returned for modification 3 February 2000.
    • Accepted 1 April 2000.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Anderson P.
    Kinase cascades regulating entry into apoptosis.Microbiol. Mol. Biol. Rev.6119973346
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Borenfreud E.,
    2. Puerener J. A.
    Toxicity determined in vitro by morphological alterations and neutral red absorption.Toxicol. Lett.241985119124
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Chen Y. J.,
    2. Zychlinsky A.
    Apoptosis induced by bacterial pathogens.Microb. Pathog.171994203212
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Cooper J. A.
    Effects of cytochalasin and phalloidin on actin.J. Cell Biol.105198714731478
    OpenUrlFREE Full Text
  5. 5.↵
    1. del Castillo I.,
    2. Leal S. C.,
    3. Moreno F.,
    4. del Castillo I.
    The Escherichia coli K-12 sheA gene encodes a 34-kDa secreted haemolysin.Mol. Microbiol.251997107115
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Fernandez-Prada C.,
    2. Tall B. D.,
    3. Elliott S. E.,
    4. Hoover D. L.,
    5. Nataro J. P.,
    6. Venkatesan M. M.
    Hemolysin-positive enteroaggregative and cell-detaching Escherichia coli strains cause oncosis of human monocyte-derived macrophages and apoptosis of murine J774 cells.Infect. Immun.66199839183924
    OpenUrlAbstract/FREE Full Text
  7. 7.
    1. Gavrieli Y.,
    2. Sherman Y.,
    3. Ben-Sasson S. A.
    Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.J. Cell Biol.1191992493501
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Gómez-Gómez J. M.,
    2. Blázquez J.,
    3. Baquero F.,
    4. Martínez J. L.
    hns mutant unveils the presence of a latent haemolytic activity in Escherichia coli K-12.Mol. Microbiol.191996909910
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Green J.,
    2. Baldwin M. L.
    The molecular basis for the differential regulation of the hlyE-encoded haemolysin of Escherichia coli by FNR and HlyX lies in the improved activating region 1 contact of HlyX.Microbiology143199737853793
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Herrmann M.,
    2. Lorenz H.-M.,
    3. Voll R.,
    4. Woith W.,
    5. Kalden J. R.
    A rapid and simple method for the isolation of apoptotic DNA fragments.Nucleic Acids Res.22199455065507
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Holm A.,
    2. Kalfas S.,
    3. Holm S. E.
    Killing of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus by human polymorphonuclear leukocytes in serum and saliva.Oral Microbiol. Immunol.81993134140
    OpenUrlPubMed
  12. 12.↵
    1. Iwase M.,
    2. Lally E. T.,
    3. Berthold P.,
    4. Korchak H. M.,
    5. Taichman N. S.
    Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans.Infect. Immun.58199017821788
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Johansson, A., L. Hänström, and S. Kalfas. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacterial proteases. Oral Microbiol. Immunol., in press.
  14. 14.↵
    1. Jonas D.,
    2. Schultheis B.,
    3. Klas C.,
    4. Krammer P. H.,
    5. Bhakdi S.
    Cytocidal effects of E. coli hemolysin on human T lymphocytes.Infect. Immun.61199317151721
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Kerr J. F. R.,
    2. Wyllie A. H.,
    3. Currie A. R.
    Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.Br. J. Cancer261972239257
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Korzeniewski C.,
    2. Callewaert D. M.
    An enzyme-release assay for natural cytotoxicity.J. Immunol. Methods641983313320
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Lai X.-H.,
    2. Wang S.-Y.,
    3. Uhlin B. E.
    Expression of cytotoxicity by potential pathogens in the standard Escherichia coli collection of reference (ECOR) strains.Microbiology145199932953303
    OpenUrlPubMedWeb of Science
  18. 18.↵
    1. Lai X.-H.,
    2. Xu J.-G.,
    3. Melgar S.,
    4. Uhlin B. E.
    An apoptotic response by J774 macrophage cells is common upon infection with diarrheagenic Escherichia coli.FEMS Microbiol. Lett.17219992934
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Libby S. J.,
    2. Goebel W.,
    3. Ludwig A.,
    4. Buchmeier N.,
    5. Bowe F.,
    6. Fang F. C.,
    7. Guiney D. G.,
    8. Songer J. G.,
    9. Heffron F.
    A cytolysin encoded by Salmonella is required for survival within macrophages.Proc. Natl. Acad. Sci. USA911994489493
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Ludwig A.,
    2. Bauer S.,
    3. Benz R.,
    4. Bergmann B.,
    5. Goebel W.
    Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12.Mol. Microbiol.311999557567
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Ludwig A.,
    2. Tengel C.,
    3. Bauer S.,
    4. Bubert A.,
    5. Benz R.,
    6. Mollenkopf H. J.,
    7. Goebel W.
    SlyA, a regulatory protein from Salmonella typhimurium, induces a haemolytic and pore-forming protein in Escherichia coli.Mol. Gen. Genet.2491995474484
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. McConkey D. J.,
    2. Orrenius S.
    Signal transduction pathways to apoptosis.Trends Cell Biol.41994370374
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Ojcius D. M.,
    2. Zychlinsky A.,
    3. Zheng L. M.,
    4. Young J. D.-E.
    Ionophore-induced apoptosis: role of DNA fragmentation and calcium fluxes.Exp. Cell Res.19719914349
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Oscarsson J.,
    2. Mizunoe Y.,
    3. Li L.,
    4. Lai X.-H.,
    5. Wieslander Å.,
    6. Uhlin B. E.
    Molecular analysis of the cytolytic protein ClyA (SheA) from Escherichia coli.Mol. Microbiol.32199912261238
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Oscarsson J.,
    2. Mizunoe Y.,
    3. Uhlin B. E.,
    4. Haydon D. J.
    Induction of haemolytic activity in Escherichia coli by the slyA gene product.Mol. Microbiol.201996191199
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Ralph P.,
    2. Nakoinz I.
    Phagocytosis and cytolysis by a macrophage tumor and its cloned cell line.Nature2571975393394
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Sundström C.,
    2. Nilsson K.
    Establishment and characterization of a human histiocytic lymphoma cell line (U937).Int. J. Cancer171976565577
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Uhlin B. E.,
    2. Mizunoe Y.
    Expression of a novel contact-hemolytic activity by E. coli.J. Cell Biochem.18A199471
    OpenUrl
  29. 29.↵
    1. Wallace A. J.,
    2. Stillman T. J.,
    3. Atkins A.,
    4. Jamieson S. J.,
    5. Bullough P. A.,
    6. Green J.,
    7. Artymiuk P. J.
    E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy.Cell1002000265276
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Wyllie A. H.
    Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation.Nature2841980555556
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Cytocidal and Apoptotic Effects of the ClyA Protein from Escherichia coli on Primary and Cultured Monocytes and Macrophages
Xin-He Lai, Ignacio Arencibia, Anders Johansson, Sun Nyunt Wai, Jan Oscarsson, Sotos Kalfas, Karl-Gösta Sundqvist, Yoshimitsu Mizunoe, Anders Sjöstedt, Bernt Eric Uhlin
Infection and Immunity Jul 2000, 68 (7) 4363-4367; DOI: 10.1128/IAI.68.7.4363-4367.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cytocidal and Apoptotic Effects of the ClyA Protein from Escherichia coli on Primary and Cultured Monocytes and Macrophages
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cytocidal and Apoptotic Effects of the ClyA Protein from Escherichia coli on Primary and Cultured Monocytes and Macrophages
Xin-He Lai, Ignacio Arencibia, Anders Johansson, Sun Nyunt Wai, Jan Oscarsson, Sotos Kalfas, Karl-Gösta Sundqvist, Yoshimitsu Mizunoe, Anders Sjöstedt, Bernt Eric Uhlin
Infection and Immunity Jul 2000, 68 (7) 4363-4367; DOI: 10.1128/IAI.68.7.4363-4367.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Escherichia coli
Escherichia coli Proteins
Hemolysin Proteins
macrophages
monocytes

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522